Skip to content
Sexuality – Lifestyle
Author:
Arkayli Biopharma, Inc.
Arkayli Biopharma Inc. Receives Study May Proceed Response to IND from FDA and SBIR Grant from NIH to Advance Clinical Development of ARK001 for a Rare Pediatric Disease
October 6, 2026